AbbVie Points 3rd Circ. To School Board Ruling In FTC Case
By Matthew Perlman ( August 31, 2020, 9:42 PM EDT) -- AbbVie Inc. has told the Third Circuit that a recent ruling involving alleged abuse of the litigation process supports the company's bid to evade Federal Trade Commission claims that it delayed generic competition for its AndroGel testosterone treatment through sham lawsuits....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.